Dr.Sofie Daineffe
ActiveSummary
Dr.Sofie Daineffe has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €696,620 and a net result of €115,264. Equity is growing by ~18.7% per year across the filed fiscal years. Its solvency ranks better than 86% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
What they do
Specialist medical practice
NACE 86220
#9 company by equity in Zemst, Health and social work sector1 site
How big
€760,184total assets 2025
- Equity
- €696,620
- Profit
- €115,264
Turnover not published (abridged schema)
Who decides
Accounts 3 d early0 of 3 deeds read
Why 93+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordLatest accounts filed on timeShow the evidence
Checked score
Score 2025
Axes · tick = 2024
Profitability88▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60,000 at 30 days acceptable
Liquidity ample (current ratio 9.62 against 8.05 in 2024; short-term debt: 6.7% and cash: 29.4% of total assets), and 8.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
91.6%
Return on assets
15.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
3 d early
2024
on the day
2023
5 d early
2022
7 d early
2021
19 d late
2020
25 d early
2019
19 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average on the deadline day; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Annual accounts filedfiscal year 2024 · micro…
- Highest result since 2018net €121,438 ▲21.4%
Financials
Fiscal year 2025Total assets €760,184Profit €115,264Solvency 91.6%Liquidity 9.62
Total assets
€760,184▲ 6.6%
2018 - 2025
Net result
€115,264▼ 5.1%
2018 - 2025
Equity
€696,620▲ 10.6%
2018 - 2025
Solvency
91.6%▲ 3.4pp
2018 - 2025
Financials · fiscal year 2025, micro schema
In the rankings
#9 company by equity in Zemst, Health and social work sector
Trend over the years
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€152,989▲ 24.9%€138,353▼ 9.6%€144,420▲ 4.4%€181,466▲ 25.7%€164,719▼ 9.2%
Net result€104,572within the sector's middle half▲ 23.8%€95,352within the sector's middle half▼ 8.8%€100,028within the sector's middle half▲ 4.9%€121,438above the sector's middle half▲ 21.4%€115,264within the sector's middle half▼ 5.1%
Equity€397,683above the sector's middle half▲ 26.8%€442,649above the sector's middle half▲ 11.3%€542,677above the sector's middle half▲ 22.6%€629,688above the sector's middle half▲ 16.0%€696,620above the sector's middle half▲ 10.6%
Total assets€543,374within the sector's middle half▲ 6.2%€567,691within the sector's middle half▲ 4.5%€642,658above the sector's middle half▲ 13.2%€713,246above the sector's middle half▲ 11.0%€760,184above the sector's middle half▲ 6.6%
Debt€145,691▼ 26.5%€125,043▼ 14.2%€99,982▼ 20.0%€83,558▼ 16.4%€63,563▼ 23.9%
Working capital€265,710above the sector's middle half▲ 33.7%€276,586above the sector's middle half▲ 4.1%€295,224above the sector's middle half▲ 6.7%€371,812above the sector's middle half▲ 25.9%€439,623above the sector's middle half▲ 18.2%
Solvency73.2%within the sector's middle half▲ 11.9pp78.0%within the sector's middle half▲ 4.8pp84.4%above the sector's middle half▲ 6.5pp88.3%above the sector's middle half▲ 3.8pp91.6%above the sector's middle half▲ 3.4pp
Current ratio7.69above the sector's middle half▲ 3.777.25above the sector's middle half▼ 0.437.72above the sector's middle half▲ 0.478.05above the sector's middle half▲ 0.339.62above the sector's middle half▲ 1.57
Return on assets (ROA)19.2%within the sector's middle half▲ 2.7pp16.8%within the sector's middle half▼ 2.4pp15.6%within the sector's middle half▼ 1.2pp17.0%within the sector's middle half▲ 1.5pp15.2%within the sector's middle half▼ 1.9pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result and balance sheet
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 9% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €760,184
Fixed assets
€269,546 ▼ 6.6%
Current assets
€490,638 ▲ 15.6%
Equity and liabilities €760,184
Equity
€696,620 ▲ 10.6%
Debt
€63,563 ▼ 23.9%
Debt's share of the balance-sheet total falls from 11.7% to 8.4%. Equity is higher and debt is lower.
Key figures and ratios
Key figures and ratios
EBITDA
€195,208▼
2024 · €209,753
Cash flow
€145,753▼
2024 · €149,726
Debt to equity
0.09▼
2024 · 0.13
ROE
16.5%▼
2024 · 19.3%
Interest coverage
401.74▲
2024 · 46.69
Debt ≤ 1 year
€51,015▼
2024 · €52,737
Debt > 1 year
€12,548▼
2024 · €30,821
Income taxes
€52,286▼
2024 · €56,091
Staff costs
€0
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
3.2%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Filed annual accounts
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €6,000 | - | - | - |
| Remuneration, social security and pensions62 | - | - | - | - | €0 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €19,941 | €20,429 | €21,804 | €28,287 | €30,488 | ▲ 7.8% |
| Other operating charges640/8 | €1,664 | €1,376 | €1,531 | €1,523 | €1,681 | ▲ 10.3% |
| Non-recurring operating charges66A | €53 | €62 | €198 | €116 | - | - |
| Gross operating margin9900 | €174,647 | €160,220 | €167,953 | €211,392 | €196,888 | ▼ 6.9% |
| Operating profit (loss)9901 | €152,989 | €138,353 | €144,420 | €181,466 | €164,719 | ▼ 9.2% |
| Financial income75/76B | €100 | €29 | €110 | €556 | €3,316 | ▲ 496% |
| Recurring financial income75 | €100 | €29 | €110 | €556 | €3,316 | ▲ 496% |
| Financial charges65/66B | €3,334 | €2,969 | €3,584 | €4,492 | €486 | ▼ 89.2% |
| Recurring financial charges65 | €3,334 | €2,969 | €3,584 | €4,492 | €486 | ▼ 89.2% |
| Profit (loss) for the period before taxes9903 | €149,755 | €135,412 | €140,946 | €177,530 | €167,550 | ▼ 5.6% |
| Income taxes67/77 | €45,183 | €40,060 | €40,918 | €56,091 | €52,286 | ▼ 6.8% |
| Profit (loss) for the period9904 | €104,572 | €95,352 | €100,028 | €121,438 | €115,264 | ▼ 5.1% |
| Profit (loss) for the period to be appropriated9905 | €104,572 | €95,352 | €100,028 | €121,438 | €115,264 | ▼ 5.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €543,374 | €567,691 | €642,658 | €713,246 | €760,184 | ▲ 6.6% |
| Fixed assets21/28 | €237,918 | €246,857 | €303,512 | €288,696 | €269,546 | ▼ 6.6% |
| Tangible fixed assets22/27 | €237,918 | €246,857 | €303,512 | €288,696 | €269,546 | ▼ 6.6% |
| Land and buildings22 | €236,388 | €246,756 | €301,055 | €283,598 | €265,725 | ▼ 6.3% |
| Furniture and vehicles24 | €1,530 | €101 | €2,458 | €5,099 | €3,820 | ▼ 25.1% |
| Current assets29/58 | €305,456 | €320,834 | €339,146 | €424,550 | €490,638 | ▲ 15.6% |
| Amounts receivable after more than one year29 | - | €9,664 | €36,788 | €67,933 | €80,219 | ▲ 18.1% |
| Other amounts receivable291 | - | €9,664 | €36,788 | €67,933 | €80,219 | ▲ 18.1% |
| Amounts receivable within one year40/41 | - | €3,087 | €4,169 | €3,276 | €324 | ▼ 90.1% |
| Trade receivables40 | - | €647 | €147 | €1,728 | €186 | ▼ 89.2% |
| Other amounts receivable41 | - | €2,440 | €4,022 | €1,548 | €138 | ▼ 91.1% |
| Current investments50/53 | - | - | €7,000 | €19,000 | €136,190 | ▲ 617% |
| Cash at bank and in hand54/58 | €228,639 | €231,074 | €209,908 | €237,761 | €223,637 | ▼ 5.9% |
| Deferred charges and accrued income490/1 | €76,818 | €77,009 | €81,281 | €96,580 | €50,268 | ▼ 48.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €543,374 | €567,691 | €642,658 | €713,246 | €760,184 | ▲ 6.6% |
| Equity10/15 | €397,683 | €442,649 | €542,677 | €629,688 | €696,620 | ▲ 10.6% |
| Contributions10/11 | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €324,732 | €369,697 | €530,277 | €617,288 | €684,220 | ▲ 10.8% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | - | - | - | - |
| Tax-exempt reserves132 | €663 | €663 | €663 | €663 | €663 | = |
| Distributable reserves133 | €322,210 | €367,175 | €529,614 | €616,625 | €683,558 | ▲ 10.9% |
| Profit (loss) carried forward14 | €60,551 | €60,551 | - | - | €0 | - |
| Amounts payable17/49 | €145,691 | €125,043 | €99,982 | €83,558 | €63,563 | ▼ 23.9% |
| Amounts payable after more than one year17 | €105,497 | €80,794 | €56,059 | €30,821 | €12,548 | ▼ 59.3% |
| Financial debts170/4 | €105,497 | €80,794 | €56,059 | €30,821 | €12,548 | ▼ 59.3% |
| Amounts payable within one year42/48 | €39,746 | €44,249 | €43,922 | €52,737 | €51,015 | ▼ 3.3% |
| Current portion of amounts payable after more than one year42 | €23,954 | €24,703 | €24,734 | €25,239 | €17,783 | ▼ 29.5% |
| Financial debts43 | €10,686 | €13,956 | €13,623 | €13,698 | €10,065 | ▼ 26.5% |
| Credit institutions430/8 | €10,686 | €13,956 | €13,623 | €13,698 | €10,065 | ▼ 26.5% |
| Trade debts44 | €897 | €4,509 | €5,565 | €300 | €17 | ▼ 94.3% |
| Suppliers440/4 | €897 | €4,509 | €5,565 | €300 | €17 | ▼ 94.3% |
| Taxes, remuneration and social security45 | €2,683 | - | - | €13,500 | €23,150 | ▲ 71.5% |
| Taxes450/3 | €2,683 | - | - | €13,500 | €23,150 | ▲ 71.5% |
| Other amounts payable47/48 | €1,527 | €1,080 | - | - | - | - |
| Accrued charges and deferred income492/3 | €448 | - | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €104,572 | €95,352 | €100,028 | €121,438 | €115,264 | ▼ 5.1% |
| + Depreciation and write-downs630 | €19,941 | €20,429 | €21,804 | €28,287 | €30,488 | ▲ 7.8% |
| Operating cash flow (approximation) | €124,512 | €115,781 | €121,832 | €149,726 | €145,753 | ▼ 2.7% |
| Investment in fixed assets (approximation) | - | -€29,368 | -€78,460 | -€13,471 | -€11,338 | ▲ 15.8% |
| Change in cash | - | €2,436 | -€21,166 | €27,853 | -€14,125 | ▼ 151% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
DR. ANNKE NELDE - GERIATRIE
BE 0562.727.484
Beauvechain · Eq €696,709
Dokter Annick De Wolf, Anesthesist
BE 0841.026.721
Lede · Eq €696,878
GABRIEL DELEU
BE 0441.266.559
Liège · Eq €697,224
DOKTER COOLS GUY
BE 0477.007.495
Sint-Katelijne-Waver · Eq €696,011
Dr. Marc Claessens
BE 0832.634.142
Schilde · Eq €695,896
Of 16,625 companies in this sector we hold annual accounts for 7,989. 6,170 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Timeline
12 eventsLatest 28-07-2026Next filing 31-07-2027
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €121,438 ▲21.4%
Operating result €181,466, net result €121,438, both a record.
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €500,000Eq €542,677 ▲22.6%
6 profitable years in a row build equity to €542,677.
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
19-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 19 days late
2021
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
19-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 19 days late
2019
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Company details
Private limited company · founded 03-01-2011Year ends 31-12Peppol reachable1 site
Register details
Identification
Legal formPrivate limited company
Founded03-01-2011
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0832400154
Also
9925:BE0832400154
Registered
16-09-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Zemst · 1 establishment unit since 2011
Ground area
921 m²
Building footprint
174 m²
Volume, LiDAR
15 m³
Parcel 23034A0188/00K000, Flanders · tallest building 4.2 m. Linked by address, not a title deed.
1 establishment unit
Ambroossteenweg 125, 1981 Zemst
since 2011unit no. 2.194.994.390
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23034A0188/00K000 | Flanders | 921 m² | 1 · 174 m² | 4.2 m |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.